Formalin-fixed, paraffin-embedded (FFPE), biobanked tissue samples offer an invaluable 88 resource for clinical and biomarker research. Here we developed a pressure cycling technology 89 (PCT)-SWATH mass spectrometry workflow to analyze FFPE tissue proteomes and applied it to 90 the stratification of prostate cancer (PCa) and diffuse large B-cell lymphoma (DLBCL) samples. 91
Introduction
reviewed 13, 14 . These studies have shown that FFPE samples can, in principle, be analyzed by 137 mass spectrometry based proteomic methods. However, the proteome maps of FFPE tissues and 138 their analogue FF tissues from clinical cohorts and their respective stability over time have not 139 been rigorously assessed. The concern remains that FFPE samples may harbor greater variation 140 in protein quality than FF samples due to formalin-induced chemical modifications 25 . 141
Multiple factors might have contributed to these limitations. First, the generation of 142 clinically meaningful results requires the consistent analysis of sizable sample cohorts. Second, 143 reproducible sample preparation and mass spectrometric analysis that are essential for clinical 144 studies have been difficult to achieve. Few if any published studies on FFPE proteomic analyses 145 have ever attempted to repeat analysis on clinical specimens of a cohort due to the complexity 146 and high cost of the adopted proteomics techniques [26] [27] [28] . Third, the ability to analyze a 147 histological region of small FFPE samples remains challenging. Most published studies analyzed 148 tissue micrometer sections with each tissue containing multiple histological types 26, 29, 30 . Laser 149 capture microdissection has been used to analyze multiple regions of a tissue section; however, 150 experimental complexities preclude application to large-scale analysis. Targeted needle punches 151 from a FFPE tissue block represent a reasonable compromise; however, efficient extraction of 152 proteins from such a small needle biopsy and further proteolytic digestion of the proteins into 153 peptides for mass spectrometric analysis has not been reported yet. Finally, although methods are 154 available to analyze proteins from human and animal FFPE samples 12 , concerns remain whether 155 the thus extracted proteins reliably reflect their actual abundance pattern in the fresh frozen 156 counterpart and ultimately, fresh samples 25 . 157 In this report we re-visited and optimized the acidic and alkaline hydrolysis procedures 158 developed in 1947 31 which are compatible with a detergent-free protocol to recover proteins 159 from small (0.5×0.5×3mm) FFPE tissue punches in a form that is directly compatible with in 160 solution digestion within an hour. The thus treated tissue samples can be directly processed by 161 the PCT method to generate mass spectrometry-ready peptide samples within a few hours 32-35 . 162 We further investigated whether the thus acquired FFPE proteome map is comparable to its 163 counterpart FF proteome map in prostate tissue samples by applying this workflow to identify 164 promising diagnostic protein biomarkers for PCa patients. We found that the two types of 165 patterns were highly similar and identified strongly overlapping sets of proteins that showed 166 different levels of expression in benign and tumor tissue. Subsequently, the effect of factors such Page 7 / 42 as storage time and FFPE tissue forms to the proteome was further evaluated. There is no 168 significant difference among FFPE proteome patterns with different storage time, while tissue 169 sections were separated from punched tissue biopsies based on principal component analysis 170 (PCA) . 171
Further, a panel of 12 proteins showing great potential for PCa diagnosis was 172 characterized in an independent Chinese prostate cohort and was validated in the Swiss cohort in 173 this study as well as in other two recently reported PCa studies 36, 37 . As a second application, the 174 FFPE PCT-SWATH workflow was employed to identify prognostic biomarkers for DLBCL 175 patients, employing the relevant archived FFPE tissues. MPO was identified as a promising 176 novel prognostic candidate for DLBCL.
Results 178

Establishment of a FFPE PCT-SWATH workflow 179
We integrated a workflow for the generation of proteome map from FFPE tissue samples 180 in a robust and high-throughput manner. In addition, we showed that the proteome map derived 181 from FFPE samples correlate well with corresponding maps generated from their analogous FF 182 samples, and that the same biomarker panel can be identified from both sample types, even if the 183 samples have been stored for 4-8 years in their respective format. The de-crosslinking of FFPE 184 tissue is based on acidic and alkaline hydrolysis which was developed in 1947 31, 38 but has not 185 been reported in proteomics research applications yet. Here we integrated the classical de-186 crosslinking method with PCT-assisted protein extraction and digestion, and SWATH-MS 32,39 187 method to establish a detergent free FFPE PCT-SWATH workflow. To achieve the desired 188 overall performance profile, protocols for the chemical extraction of proteins from FFPE tissue, 189 liquid chromatography (LC), SWATH-MS, and data analysis were optimized and integrated. 190
Chemical extraction of proteins from FFPE tissue punches. A detergent-free and fast 191
hydrolysis protocol for preparing MS-ready peptides from FFPE tissue punch samples 192 mimicking needle biopsies (width < 1mm, length ~2-3mm; dry mass weight about 300~400µg) 193 ( Fig. 1a ) was optimized. The method consists of i) an acidic hydrolysis step (0.1% formic acid) 194 to achieve C-O hydrolysis of protein methylol products ( Fig. 1b) , ii) a step of heat and base 195 induced hydrolysis to reverse the C-N methylene crosslinks ( Fig. 1b, 1c ) and iii) extraction and 196 digestion of proteins from the thus pre-treated punches by PCT ( Fig. 1c) . The FFPE tissue 197 biopsies used for the protocol establishment were from a sample pool of 48 replicate tissue 198 biopsies extracted from a resected prostate of the ProCOC cohort 40,41 . We optimized the acidic 199 and alkaline hydrolysis steps by varying the respective treatment times. Acidic hydrolysis was 200 achieved concurrent with the complete rehydration of FFPE tissue punches by replacing water 201 with 0.1% formic acid. Preliminary UV-spectroscopy results showed that the release of methylol 202 groups began saturated in 30 min. As to the alkaline hydrolysis, the effects of the different tested 203 conditions were evaluated by determining the peptide yield as well as the number and type of 204 peptides and proteins identified from each sample by SWATH-MS ( Fig. 1d and Fig. 1e The yield was comparable to our previous investigations of fresh frozen tissues (wet tissue) 209 32, 33, 42, 43 . 210 
218
Optimization of LC and SWATH-MS. We assessed the combined effects of LC gradient 219 length (30 min, 45 min and 60 min) and SWATH window configuration (eight configurations, 220
Page 10 / 42 ranging from 20 to 93 variable windows) on sample throughput, proteome depth and 221 reproducibility. Each window scheme assessed was based on equal segmentation of precursor 222 ion signals over the entire mass range. The peptides used for the optimization of LC and 223 SWATH settings were randomly selected from 9 peptide samples obtained from FFPE tissues 224 processed with the 30 min alkaline hydrolysis protocol described above (Fig. 1e) . Altogether, we 225 compared 24 LC-SWATH conditions in duplicate ( Supplementary Fig. 1a-1c) . The results 226 showed that 48 variable SWATH windows achieved the highest number of peptide and protein 227 identifications. We observed a trade-off between the gradient length and proteome coverage. The 228 30 min LC gradient resulted in a 19% lower number of peptide identifications and 8% fewer 229 protein identifications, compared to the 60 min LC gradient ( Supplementary Fig. 1b and 230 Supplementary Fig. 1c ). 231
232
Comparison of FFPE and FF tissue proteome maps 233
To investigate whether the obtained FFPE proteome maps were comparable to their FF 234 counterparts, we performed proteomic analyses of corresponding FFPE and FF counterpart tissue 235 samples of 24 PCa patients with radical prostatectomy from the ProCOC cohort 40,41 . Sections of 236 tissue samples from the same resected prostates have been stored for four to eight years in the 237 form of FFPE or FF, respectively, prior to proteomic analysis ( Fig. 2a, Supplementary Table 1) . 238
Only the index tumor with the highest Gleason score and the largest diameter was selected for 239 analysis. For non-tumorous tissue, benign prostatic tissue with minimal stromal component was 240
chosen. 241
With respect to FFPE tissues, three replicate punches were processed via the FFPE PCT-242 SWATH workflow for each sample and combined for PCT-SWATH analysis. The size of each 243 tissue biopsy was around 0.6×0.6×3mm, weighing approximately 300µg including wax. In total, 244 approximately 900µg of dry mass weight was available per FFPE sample. For the FF cohort, one 245 tissue punch of approximately 1mm 3 size and wet weight of about 800µg per sample was 246 processed by PCT-SWATH. Altogether, 48 FFPE tissue samples (benign and tumor) were 247 processed into peptide samples that were analyzed by SWATH-MS in technical duplicates. Fig.  248 1f shows that the samples produced on average about 60µg injection-ready peptide mass per 249 milligram of tissue sample. The yield is consistent with previous reports for FF tissues 32, 33, 42 . 250
The CV values of peptide yield were 49% and 65% for benign and tumorous tissues respectively, slightly higher than the corresponding figures reported previously for FF tissues 33,42 . The 252 difference in peptide yield is likely caused by inaccurate estimation of FFPE tissue weight due to 253 variable wax content and the heterogeneity of human prostate tissues. 254
The setting of 30 min LC integrated with 48 variable SWATH windows was adopted for 255 protein measurement to compare FFPE and FF tissue proteome maps in this study. Two technical 256 replicates for each tissue digest were analyzed using SWATH-MS, referred to in the following as 257 PCF dataset. The resulting SWATH-MS data from all 96 FFPE and FF samples were compared 258 by their total ion current and the number and type of peptides as well as proteins that could be 259 identified and quantified. 260
We first compared the raw ion intensity signals over chromatographic time (total ion 261 chromatogram, TIC) at both the MS1 and MS2 levels. We found that the TIC, normalized for 262 total injected peptide mass, was on average 15% higher for FF than for FFPE samples 263 ( Supplementary Fig. 2) . The observed small discrepancy of normalized MS1 intensity values is 264 likely due to incomplete acidic and alkaline hydrolysis of cross-links, resulting in the generation 265 of partially hydrolyzed methylene bridges, which contribute to the absorbance in the range from 266 260-280nm on the spectroscopy. The modification by formalin could also lead to ion suppression. 267
The root cause for lower specific TIC was not further investigated because the effect was minor 268 and the contour of the TIC for FF and FFPE samples were very similar, suggesting that 269 comparable peptide populations were generated from both sample types ( Supplementary Fig. 2) . 270
Next, we used the SWATH-MS fragment ion maps to compare the number and type of 271 peptides and proteins that could be identified from FF and FFPE samples, and their respective 272 quantities. We used the OpenSWATH 44 software tool and a spectral library built from prostate 273 tissue, consisting of 70,981 peptide precursors from 6,686 SwissProt proteins, to search the 274 acquired fragment ion maps. Altogether, we obtained quantitative data for 3,030 SwissProt 275 proteins inferred from 18,129 proteotypic peptides. The median technical CV analyses were 14.9% 276 and 17.5% for FF and FFPE samples, respectively. Overall median CV was 16.2% ( Fig. 2b , 277 Supplementary Fig. 3 ). We further compared the overall proteomic variation for different tissue 278 types including benign and tumorous FFPE versus FF samples, and found no significant 279 discrepancy ( Supplementary Fig. 4 ). We then compared the peptide precursors and proteins 280 detected in each paired FFPE and FF sample (Supplementary Fig. 5 ) and found that peptides as 281 well as proteins were consistently quantified in both tissue types with relatively high Pearson Page 12 / 42 correlation. The overall correlation between FFPE and FF samples reached a Pearson correlation 283 of 0.91 ( Fig. 2c) with a median normalization of the data based on protein abundance. With 284 unsupervised clustering, the proteome map from FFPE samples was mixed with FF samples 285 ( Supplementary Fig. 6a ), further supporting the notion that the data generated from FFPE 286 samples are comparable with those of FF samples. Curated MS signals by the viewer function of 287 the DIA-expert software for a representative peptide which was quantified across all 224 288 SWATH runs are shown in Supplementary Fig. 6b . We further compared the raw signals, 289 quantity of peptide precursors and proteins in samples stored for different periods of time and 290 observed no significant impact of storage time (Supplementary Fig. 7) . 291
Overall the data show that a highly consistent and significant fraction of the whole 292 We next evaluated the robustness of proteome maps obtained from FFPE tissue stored in 319 different formats and for different periods of time. We procured FFPE tissue samples from three 320 BPH patients from China (termed as 'PCZC' cohort). For each patient, we collected both tissue 321 sections (5 µm thickness) and punched tissue biopsies (1×1×0.5 mm). For each sample format 322 we analyzed three biological replicates. The samples had been archived for different periods of 323 time, specifically for 1 year, 5 years, 10 years and 15 years, respectively. Altogether, 72 tissue 324 samples were processed, and 72 SWATH files were acquired with a 90 min LC gradient in a 325
TripleTOF 5600+ mass spectrometer coupled to an Eksigent micro-flow system. 326
We reproducibly quantified 3,040 SwissProt proteins in both tissue punches and sections 327 in this data set. By comparing the protein abundance distribution of these common proteins, we 328 found that the proteome maps of the two FFPE formats showed a high degree of similarity, with 329 a Pearson correlation coefficient of 0.95 (Fig. 3a) . The mean Pearson correlation coefficient of 330 all 72 samples among their own biological replicates was 0.858, showing that the samples were of high similarity at the whole proteome level (Fig. 3b) . Unsupervised cluster analysis of all 332 3,040 proteins also showed consistent distribution of protein abundance among all 72 samples 333 ( Fig. 3c) . We further grouped the 72 samples into eight groups according to sample format and 334 storage time, and investigated the biological variation of nine samples (three patients, each with 335 three biological replicates) in each group. The average CV slightly varied between tissue 336 micrometer sections and punches across the time span of 15 years (Fig. 3d) . Further, tissue 337 micrometer sections were found to be different from punches (Fig. 3e) , probably due to that fact 338 that tissue micrometer sections cover more diverse tissue regions and therefore contain higher 339 degree of the spatial heterogeneity 43 . However, these differences only affected a small portion of 340 proteins. The duration of FFPE storage did not impact on our proteomic measurement, further 341 reinforcing the stability of FFPE proteome and the robustness of our protocol (Fig. 3f) . 
Identification of a subset of proteins with comparable abundance patterns in prostate 355
FFPE and FF punches 356
Next, we asked whether proteins distinguishing benign and tumorous prostate tissue 357 could be consistently detected in both FFPE and FF samples. We observed differential 358 expression of multiple proteins between benign and tumorous tissues in both FFPE and FF 359 samples in the PCF cohort. 360
We first determined proteins that were significantly differentially regulated between the 361 FF tumor and benign samples. We computed the median fold-change of tumor-to-benign tissue 362 samples and the P values for each protein in the 24 patients for FF tissue samples. By setting a 363 fold-change (FC) cutoff of 2 and a P value cutoff at 0.05, only three proteins were significantly 364 up-regulated in tumor compared to benign tissue. These were Q15063 (POSTN), O95994 (AGR2) 365 and Q9BUD6 (SPON2). Remarkably, these three proteins are all promising biomarker 366 candidates. POSTN is an extracellular matrix protein involved in cell development and adhesion. 367
We have previously reported its upregulation in high grade and advanced stage PCa patients 45 , 368 which is consistent with an independent report of its positive prognostic value in PCa 46 , and with 369 a study of its positive correlation with the aggressiveness of PCa 47 . AGR2 is a secreted 370 adenocarcinoma-associated antigen. The mRNA level of AGR2 was found higher in cancerous 371 tissue in 42 paired PCa samples, but it was not associated with survival in the cohort 48 . In 372 addition, the protein expression level of AGR2 was found increased in cancerous tissue in 31 out 373 of 58 PCa cases by IHC immunolabeling 48 , a result that was consistent with two independent 374 cohorts 49 . In this study, the expression of AGR2 was found to be about four times higher in 375 tumor compared to benign tissue and, remarkably, it's abundance level positively correlated with 376 survival (P = 0.008). SPON2 is a secreted extracellular matrix protein. In a previous study, it was 377 detected as an abundant protein in serum samples of 286 PCa patients compared to 68 healthy 378 controls 50 . In particular, it was found with significantly higher expression levels in PCa patients 379 with a Gleason score of 7-8 and in PCa patients with metastases 50,51 . In our FF data set, SPON2 380 was found to be expressed 2-4 times higher in malignant compared to corresponding benign 381 tissue samples. 382
We then analyzed the SWATH data acquired for FFPE samples in the same way and 383 found 24 proteins with significantly different abundance between tumor and benign groups. The 384 results from the FFPE cohort recapitulated the pattern of the three proteins with increased tumor 385 abundance identified in the FF cohort. The consistency of the detected changes for these 386 proteins is remarkable given the intra-tumor heterogeneity, expected differences between the FFPE and FF proteomes and the fact that the FFPE and FF samples were from different regions 388 of the tumors. In addition to these three proteins, a further eight proteins were detected at 389 increased abundance in FFPE tumor compared to benign tissue and thirteen proteins were 390 detected at lower abundance in the tumor vs. benign samples (Fig. 1d) . 391
To verify whether the findings from our SWATH data set of ProCOC 40 patients are 392 consistent with IHC reports, we analyzed a tissue microarray from 18 patients which were also 393 part of the cohort analyzed by PCT-SWATH. Representative staining images of POSTN are 394 shown in Fig. 2h . We scored the staining patterns into four grades (0, 1+, 2+, and 3+), and 395 compared the results with the SWATH signals of the corresponding FF and FFPE samples. We 396 analyzed the statistical significance by pair-wise comparison of groups using Students' t-test, and 397 single factor ANOVA ( Fig. 2i, Supplementary Table 2 ). We did not observe any significant 398 difference between the data from FF samples and from FFPE at the level of the mass 399 spectrometry data. Remarkably, the ANOVA analyses revealed significant correlation between 400 IHC and both FF (P value 3.3×10 -6 ) and FFPE (P value 6.7×10 -5 ) SWATH data. Taken together, 401 via the IHC results an orthogonal technique confirmed the similarity of POSTN abundance 402 patterns of POSTN detected in FFPE and FF samples by mass spectrometry. Nevertheless, the 403 difference among the IHC groups 0, 1+ and 2+ appeared mostly insignificant at the SWATH 404 level. The prognostic role of POSTN was further confirmed in the survival analysis based on the 405 TMA data (Fig. 2j) . In an independent Swiss TMA cohort, we also observed significantly higher 406 abundance of POSTN (P value < 0.001 by Fisher's exact test, Fig. 2k ) in tumor vs, benign tissue. 407
We then checked the functions and applications of the 24 proteins significantly regulated 408 proteins in the FFPE sub-cohort based on literature mining. Here we discussed some of them 409 which had been studied and reported extensively. Q7L266 (ASRGL1) was found to be 410 significantly upregulated in FFPE tumor samples, whereas the quantitative difference in FF 411 samples was not significant. The full name of ASRGL1 is isoaspartyl peptidase/l-asparaginase 412 protein, which is an enzyme involved in the production of l-aspartate. ASRGL1 was over-413 expressed in PCa and regarded as the potential diagnostic and therapeutic target 52 . Among the 414 13 down-regulated proteins identified in FFPE cohort, desmin (DES, P17661) is a known marker 415 protein for prostate smooth muscle 53 . The decreased abundance of DES in tumor tissue is 416 consistent with the replacement of smooth muscle tissue by malignant cells. We also found that 417 c-Src tyrosine kinase (CSK, P41240), a regulator of SRC kinase 54 , was found to be down-regulated in tumor tissue. With respect to decorin (DCN, P07585), a proteoglycan in the tumor 419 microenvironment, our data for the first time report its down-regulation in association with PCa 420 prognosis. This observation is in line with a previous mouse-based functional study reporting 421 that DCN specifically inhibits EGFR and AR phosphorylation, leading to suppressed AR nuclear 422 translocation and inhibition of PSA production 55 . While most protein changes were detected in 423 both tissue types, the FFPE samples exposed the protein regulation with better statistical power 424 ( Fig. 2) . POSTN was detected to be significantly upregulated in both FF and FFPE tumor 425 samples in this cohort. CSK and DCN were only significant in the FFPE cohort, indicating the 426 FFPE proteomes analyzed by our method are more robust. 427 Furthermore, by integrating the seven proteins (POSTN, AGR2, SPON2, ASRGL1, DES, 428 CSK, and DCN) discussed above, we achieved an AUC of 0.983 for FF samples and 0.977 for 429 FFPE samples, respectively (Fig. 4a) We applied the same workflow as above to another cohort from China (in the following 445 termed as 'PCZA' cohort) to stratify PCa. The PCZA cohort contains samples from 58 PCa 446 patients and 10 benign prostate hyperplasia (BPH) patients that have been stored as FFPE 447 samples for up to 2 years. Three punches for each sample were analyzed. Of these samples, we 448 randomly selected 33 for technical replicates (Supplementary Table 3) . Altogether, 237 449 SWATH files were acquired. To cover more proteins, we adopted an extended 120 min LC 450 gradient in a TripleTOF 5600+ coupled to an Eksigent micro-flow system. The resulting data 451 were processed as described above. From 4,144 SwissProt proteins quantified with high degree 452 of reproducibility ( Supplementary Fig. 8 ) in this data set, we identified 241 up-regulated 453 proteins and 89 down-regulated proteins (adjusted P value cutoff 0.05, FC cutoff 2) ( Supplementary Table 3, Supplementary Fig. 8 ). We performed ingenuity pathway analysis 455 (IPA) 56 of these significantly regulated proteins between PCa and BPH groups and found that 456 five top upstream regulator pathways were enriched from these proteins ( Supplementary Table  457 4). MYCN, MYC, TCR regulator pathways were activated while sirolimus and 5-fluorouracil 458 regulator pathways were inhibited (Supplementary Table 4) . 16 cellular networks were 459 enriched from these proteins via IPA analysis (Supplementary Table 4) . 460 PCZA and PCF datasets shared seven common regulated proteins in prostate tumor 461 tissues, which are O14773 (TPP1), O95994 (AGR2), P22626 (HNRNPA2B1), P40926 (MDH2), 462 Q9BUD6 (SPON2), P17661 (DES), Q7L266 (ASRGL1), as shown in Fig. 4b . Besides, other 463 significantly regulated proteins, including P07288 (KLK3), Q00796 (SORD), P21333 (FLNA), 464 P09936 (UCHL1), and Q9UKU7 (ACAD8), were also identified to show diverse functions by 465 IPA analysis ( Fig. 4b, Supplementary Table 4) . These proteins were enriched in nine networks 466 by IPA analysis, as shown in Supplementary Fig. 9 . The relative abundance of these proteins in 467 both cohorts was calculated and the regulation pattern of them in two cohorts was consistent with 468 each other, as was shown in and Chinese cohorts (Supplementary Fig. 8) . By loosening the threshold for significantly 479 regulated proteins in PCF cohort, more proteins would be distinguished out to be deregulated 480 between tumor and benign conditions, as was shown in Tripeptidyl-peptidase 1 (TPP1) was found to be upregulated. TPP1 is a primary protector 499 of telomere DNA and has been reported to be an effective anticancer target for about 90% of 500 human tumors that are telomerase-positive 61 . Heterogeneous nuclear ribonucleoproteins 501 (HNRNPs) associate with nascent pre-mRNAs, and package them into HNRNP particles in a 502 sequence-dependent way. HNRNP particles serve to condense and stabilize the transcripts and 503 minimize tangling and knotting. The splicing factor HNRNPA1 has been reported to contribute 504 to enzalutamide resistance by promoting AR-V7 62 . In this study, HNRNPA2B1 was found to be 505 a novel upregulated protein probably modulating splicing in PCa cells. Malate dehydrogenase 2 506 (MDH2) was also up-regulated in prostate tumor tissues in both PCF and PCZA cohort in this 507 study. MDH2 is a mitochondrial enzyme that catalyzes the NAD/NADH-dependent, reversible 508 oxidation of malate to oxaloacetate. Interestingly, a very recent report on integrative proteomics 509 in PCa uncovers two metabolic shifts in the citric acid cycle (TCA cycle) during PCa 510 development and progression, among which MDH2 is a component. Increased MDH2 511 expression in PCa correlated with an increase in mRNA levels, and it is further upregulated in 512 CRPC samples 36 . Together, these data suggest that development of MDH2 inhibition could be of 513 great benefit against progressed PCa. Besides, ACAD8, the acyl-CoA dehydrogenase family 514 member 8, was detected to be upregulated in tumor tissues in this study. It has been reported to 515 be a potential prognosis biomarker indicating the outcome of prostate tumors 63 .
We further applied the 12-protein panel to both the Swiss and Chinese PCa cohorts, to 517 evaluate the sensitivity and specificity in diagnosis of PCa. These proteins and their ROC curves 518 using the PCF and PCZA FFPE data sets are shown in Fig. 4b . They exhibited high AUC values. 519
Integrative models demonstrated AUC values of 1 in the FFPE samples of the PCF cohort. In the 520 independent PCZA cohort, the AUC reached 0.991. An independent FFPE cohort from a 521 different country therefore confirmed the diagnostic significance of these novel proteins in PCa. 522
Taken together, these findings demonstrate that our proteomic methodology is robust and has the 523 capacity to uncover new diagnostic protein biomarkers for PCa. 524
Subsequently we identified differentially expressed proteins distinguishing patient groups 525 classified by Gleason scores. In this study, 24 PCa patients from the PCF cohort and 58 PCa 526 patients from PCZA cohort were classified into three groups according to their tumor grades as 527 reflected by Gleason, namely, low (L), intermediate (M), and high stage (H) (Supplementary 528 Table 5 ). ANOVA analysis was employed to compare proteomes among three stages to identify 529 protein candidates that distinguish different stages of cancer progression (P value < 0.05). 216 530 proteins and 373 proteins were detected significantly regulated in the PCF cohort and the PCZA 531 cohort, respectively ( Supplementary Table 5 ), with 23 proteins overlapping. PCA analysis 532 ( Supplementary Fig. 10 ) demonstrated clear separation of L and H grades, however, it was 533 challenging to distinguish M from L and H grades, consistent with the pathological nature of the 534 samples, indicating that proteome acquired by our method well preserved the granularity of the 535 FFPE tissue samples. 536 537
Prognostic markers for diffuse large B-cell lymphoma (DLBCL) 538
Having established that the PCT-SWATH method was applicable to analyze prostate 539 FFPE samples and to consistently distinguish malignant and benign samples in two independent 540 sample cohorts, we next asked whether the method could stratify other types of tumors based on 541 overall survival. We procured 41 patients with DLBCL (in the following termed as 'WLYM' 542 cohort) from the University Hospital Zurich to investigate prognostic markers. DLBCL is a 543 disease with relatively poor prognosis and includes different subtypes, i.e. lymphomas residing 544 exclusively in the brain, known as primary central nervous system lymphomas (PCNSL) and 545 extracerebral DLBCL (eDLBCL). Another distinct entity, intravascular lymphoma (IVL), is a 546 rare type confined to the lumina of blood vessels (there is only one IVL patient in WLYM cohort, Supplementary Fig. 11) . About 70% cases of eDLBCL are curable, however, the median 548 survival of patients with PCNSL is only about 30 months in contemporary clinical trials 64 . 549
To identify prognostic proteins for DLBCL, two to three FFPE punches were analyzed 550 for each of the 41 DLBCL tumors (Supplementary Table 6, Supplementary Fig. 11, 12) . 551
Altogether, we acquired 113 SWATH maps using a 60 min LC gradient, and a TripleTOF 6600 552 mass spectrometer. We quantified 5,769 SwissProt proteins in all samples (Supplementary 553 Table 6 ). The technical reproducibility for a representative sample is shown in Supplementary  554   Fig. 11d . 91 proteins were detected to be significantly up-regulated and 6 proteins were detected 555 to be down-regulated in the PCNSL tumors compared to eDLBCL tumors (Supplementary Fig.  556 11e, Supplementary Table 6 ). Of these, 20 proteins were suspected to be contaminants from 557 brain tissue based on their brain tissue expression annotation in the DAVID database and the 558 human protein atlas ( Supplementary Table 6 ) 65 . 17 proteins were further selected from the 559 remaining 77 proteins according to their applications in biomarker and drug target studies as 560 revealed by IPA analysis 56 ( Supplementary Table 6 ). Their relative abundance of these 561 proteins in both eDLBCL and PCNSL groups is shown in Supplementary Fig. 13 . 562 ROC analyses based on these seventeen proteins in both eDLBCL and PCNSL patient 563 samples from WLYM cohort were performed. Two proteins including glial fibrillary acidic 564 protein (P14136, GFAP) and zeta chain of T cell receptor associated protein kinase 70 (P43403, 565 ZAP70) exhibited high AUC values (Fig. 6a) to differentiate eDLBCL and PCNSL subtypes of 566 DLBCL. GFAP is a class-III intermediate filament and a cell-specific marker that distinguishes 567 astrocytes from other glial cells during the development of the central nervous system. We found 568 that GFAP is a novel upregulated marker in PCNSL. ZAP70 is a tyrosine kinase that is essential 569 for initiation of T cell antigen receptor signaling. ZAP70 deficiency is associated with 570
Immunodeficiency 48 that is a form of severe immunodeficiency characterized by a selective 571 absence of CD8+ T-cells 66 . Here we found that ZAP70 was upregulated in the eDLBCL subtype 572 compared with PCNSL, indicating the role of ZAP70 in immunological processes during the 573 progress of the disease. 574
To further investigate the prognostic value of the proteins identified above, we procured a 575 second cohort of 52 eDLBCL patients from China (in the following termed as 'ZLYM' cohort), 576 and performed FFPE PCT-SWATH analysis using a TripleTOF 5600+ coupled to an Eksigent 577 micro-flow LC system (Supplementary Table 7) . Two biological replicates were analyzed for each patient. Here we quantified 6,266 proteotypic SwissProt proteins in 52 micro-sectioned 579 tissue samples from these DLBCL patients in technical duplicate. 16 out of 17 proteins identified 580 in the WLYM cohort described above were also identified in the ZLYM cohort. Survival 581 analysis of the 16 proteins in both groups of eDLBCL patients (WLYM and ZLYM) was further 582 performed through Kaplan-Meier plot. The result showed that besides ZAP70, five additional 583 proteins namely crystallin alpha B (P02511, CRYAB), Golgi membrane protein 1 (Q8NBJ4, 584 GOLM1), myeloperoxidase (P05164, MPO), microtubule associated protein 1A (P78559, 585 MAP1A) and ubiquitin C-terminal hydrolase L1 (P09936, UCHL1), were found to show 586 consistent trend in predicting the survival outcome in both WLYM and ZLYM eDLBCL patient 587 cohorts, although the P values in most cases are not very significant due to the small size of the 588 cohorts that were available for this rare disease (Fig. 6b) . CRYAB has the function of preventing 589 aggregation of various proteins under a wide range of stress conditions. GOLM1 is highly 590 expressed in colon, prostate, trachea and stomach. Our study identified them as novel biomarkers 591 for eDLBCL patients. 592 MPO is a lysosomal protein known as expressed in azurophilic granules (primary 593 lysosomes) of normal myelomonocytic cells which is released into the extracellular space during 594 degranulation. MPO functions as part of the host defense system of polymorphonuclear 595 leukocytes. It is responsible for microbicidal activity against a wide range of organisms. MPO 596 has been reported to be related to myeloperoxidase deficiency (MPOD) that is characterized by 597 decreased myeloperoxidase activity in neutrophils and monocytes that results in disseminated 598 candidiasis 67 . MAP1 is a structural protein involved in the filamentous cross-bridging between 599 microtubules and other skeletal elements. MAP1A/B are neuron specific microtubules 68 . 600 MAP1S has been reported to interact with mitochondrion-associated leucine-rich PPR-motif 601 containing protein (LRPPRC) that interacts with the mitophagy initiator and Parkinson disease-602 related protein Parkin 69 . UCHL1 gene mutations are involved in Parkinson disease 5 (PARK5) 603 that is characterized by a complex neurodegenerative disorder with manifestations ranging from 604 typical Parkinson disease to dementia with Lewy bodies 70 . As discussed above, UCHL1 is also a 605 tumor suppressor in a broad range of cancers including PCa. eDLBCL patients with lower 606 expression level of MPO, MAP1, UCHL1 and ZAP70 were found to have higher survival rate in 607 this study.
Higher expression of MPO in eDLBCL patients was associated with worse survival, as 609 was shown in Kaplan-Meier plot (Fig. 6b) . IHC staining of MPO in DLBCL tumors from two 610 patients in WLYM cohort confirmed the presence of MPO-positive regions (Fig. 6c) 
Discussion
Most archived tissues in pathology collections exist as FFPE samples, representing a rich 628 resource for clinical research. Over the past decade, MS-based shotgun proteomics has been used 629 to analyze proteins from FFPE samples 12-14,18-24,72 . However, the concern remains that FFPE 630 samples may harbor greater variation in protein quality than FF samples due to formalin-induced 631 chemical modifications 25 (Supplementary Fig. 6) . A further overall investigation 648 of FFPE sample proteome maps storing from 1 year to 15 years in an independent cohort (PCZC) 649 did not show significant pattern differences either (Fig. 3) . Besides, proteome maps from two 650 types of FFPE tissue forms (sections vs. punches) are generally similar, however, they could be 651 separated from each other by PCA analysis (Fig. 3) . 652
Since proteins in FFPE tissue are extensively and substantially modified by formalin 14,73 , 653 one would not expect complete recovery of the entire proteome, and quantitatively identical 654 recovery of every peptide in various samples. Previous studies have investigated this issue in 655 depth 74, 75, 76 . Indeed, we observed a slight global difference in TIC between comparable FFPE 656 and FF proteomes (Supplementary Fig. 2) . However, we also show that these differences do not 657 distort the proteome patterns to a degree that would preclude their use for tissue classification, throughput SWATH-MS proteotyping of fresh clinical tissue samples (five 5 µm slices for each 690 sample) of 10 BPH patients, 17 untreated PCa patients and 11 CRPC. In PCa vs BPH, they 691 quantified 3,394 proteins, which is comparable with our results regarding to quantified protein 692 number. Moreover, ACO2 and MDH2, two components in TCA cycle during PCa development 693 and progression were identified 36 . In our study, the overexpression of MDH2 in PCa tissues in 694 both PCF and PCZA cohort was characterized, which was consistent with Latonen's report. 695
Venn diagram showed that PCF, PCZA and Latonen cohorts shared 2,277 common proteins in 696 total, representing 67% of the Latonen proteome, as was shown in Supplementary Fig. 14 and  697 Supplementary Table 8 . PCF, PCZA and Iglesias-Gato cohorts shared 700 proteins in total, 698 representing 57% of the quantified proteome by Iglesias-Gato. Besides, in Iglesias-Gato cohort, 699 five proteins from our 12-protein panel were found to be significantly regulated, which were 700 MDH2, TPP1, UCHL1, FLNA, and ACAD8. In Latonen cohort, six proteins, MDH2, TPP1, 701 AGR2, DES, HNRNPA2B1, and ACAD8 were found to be significantly regulated. Detailed 702 information of protein regulation of the twelve-protein biomarker candidates was shown in 703 Supplementary Table 8 . The four cohorts revealed common proteins biomarkers and showed 704 good consistence although there were biological differences. Taken together, the presented data 705 not only demonstrate the practicality of using FFPE samples for robust PCa biomarker discovery, 706 more importantly, it also identified a panel of protein biomarker candidates for PCa diagnosis, 707 among which MDH2, TPP1 and ACAD8 were most significant regardless of tissue formats 708 (fresh or FFPE, punch or micrometer section) and patient populations. The overlap of the four 709 proteomes confirmed the technical reliability, robustness and transferability of our FFPE PCT-710 SWATH pipeline among different studies, cohorts and laboratories from another point of view. 711
The hereinabove studied PCa cohort offers a rational model to benchmark the similarity 712 of FFPE and FF proteome due to the availability of both types of tissue samples from adjacent 713 regions with relatively high degree of homogeneity. However, PCa patients generally exhibit 714 positive prognosis after prostatectomy. To further explore the generic applicability of the method 715 and to explore the feasibility of identifying prognostic markers in another clinical setting, we 716 analyzed 113 FFPE samples from a cohort of 41 Swiss DLBCL patients from Zurich with up to 717 125-month follow-up. We further validated the methodology and findings using the 718 independently established FFPE PCT-SWATH platform in China, which comprised 52 Chinese 719 DLBCL patients with up to 100-month follow-up. Importantly, data from the two cohorts confirmed MPO as a promising survival marker (Fig. 6) . The discovery of MPO as a potential 721 prognostic marker for DLBCL is also supported by the finding that circulating monocytes and 722 neutrophils are reported to be independent prognostic factor for DLBCL 78 Samples were collected within the ProCOC study 40 , a prospective ongoing biobanking trial led 737 by PJW and CP. The size of a single FF tissue biopsy was about 1mm 3 (diameter 1 mm; length 738 1-2 mm; wet weight was about 800 µg). The size of a single FFPE punch is about 0.5×0.5×3mm; 739 and the dry mass weighed about 300 µg including wax (Fig. 1a) . The DLBCL study here was also approved by ethics committee of Westlake University. 769 770
De-paraffinization, Rehydration, and Hydrolysis of FFPE tissues 771
The FFPE tissue was put into a 2 mL safe-lock Eppendorf tube, and was firstly subjected 772 to the dewaxing step by incubation with 1mL of heptane, and then gently vortexed at 800rpm for 773 10 min at 30 °C on a thermomixer (cap closed). The dewaxing was repeated once. The sample 774 was then subjected to gradient rehydration steps and gently vortexed at 800 rpm with 1ml 100%, 775 
PCT-assisted tissue lysis, protein extraction, and protein digestion 790
Briefly, the FFPE tissue sample was lysed with lysis buffer in a barocycler NEP2320-45k 791 (PressureBioSciences Inc.) at the PCT scheme of 30s high pressure at 45kpsi plus 10s ambient 792 pressure, oscillating for 90 cycles at 30°C. Then the extracted protein solution was reduced and alkylated by incubating with 10mM tris(2-carboxyethyl)phosphine (TCEP) and 20mM 794 iodoacetamide (IAA) at 25°C for 30 min, in darkness, by gently vortexing at 800rpm in a 795 thermomixer. Afterwards, proteins were firstly digested by Lys-C (Wako; enzyme-to-substrate 796 ratio, 1:40) in the barocycler using the PCT scheme of 50s high pressure at 20kpsi plus 10s 797 ambient pressure, oscillating for 45 cycles at 30°C. Then a subsequent tryptic digestion step 798 followed (Progemga; enzyme-to-substrate ratio, 1:20) using the PCT scheme of 50s high 799 pressure at 20kpsi plus 10s ambient pressure, oscillating for 90 cycles at 30°C. Peptide samples 800 were then acidified by TFA prior to C18 desalting. The FF tissue samples were processed as 801 described previously 32 with only the change of replacing the normal microcaps with 802 micropestles 33 . 803
804
SWATH mass spectrometry 805
All samples were spiked with iRT peptides (Biognosysis) 80 The research groups of R.A. and T.G. are supported by SCIEX, which provides access to 902 prototype instrumentation, and Pressure Biosciences Inc., which provides access to advanced 903 sample preparation instrumentation. 904
